☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, $0.001 par value
|
ISR
|
NYSE American
|
10.1
|
Addendum No. 3 to Supply Contract, dated April 11, 2022, by and between Isoray Medical, Inc. and Joint Stock Company. | |
10.2 | Addendum No. 4 to Supply Contract, dated April 11, 2022, by and between Isoray Medical, Inc. and Joint Stock Company. | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
Exhibit 10.1
Addendum No. 3 dated 16.03.2022 Contract № 840/08625142/31/22-21 |
THE SELLER Isotope - Regional Alliance, Joint-Stock Company (Isotope JSC) Pogodinskaya str., 22, Moscow, 119435, Russia. Phone: +7 (495) 981-96-16/17 |
THE BUYER The Company IsoRay Medical Inc. 350 Hills Street, Suite 106 Richland, WA 99354-5411 USA |
THE BUYER and THE SELLER have mutually agreed on the following: Consignee under the Contract may be the following organization: Moving Forward International GmbH Cargo City South, Bldg 638b, 60549 Frankfurt, Germany Tel.: +49 (0) 69 9686 123 10 Airport of destination: Frankfurt, Germany |
All other terms and conditions are in accordance with Contract No. 840/08625142/31/22-21, Addendum 1-2. The present Addendum No.3 is an integral part of the Contract and may be signed via facsimile or e- mail. |
/s/Konstantin Ershov, Head of Supplies THE SELLER
|
/s/Jennifer Streeter, COO, March 16, 2022 THE BUYER |
Exhibit 10.2
Certain identified information has been excluded from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.
Addendum No. 4 dated 30.03.2022 Contract № 840/08625142/31/22-21 |
THE SELLER Isotope - Regional Alliance, Joint-Stock Company (Isotope JSC) Pogodinskaya str., 22, Moscow, 119435, Russia. Phone: +7 (495) 981-96-16/17 |
THE BUYER The Company IsoRay Medical Inc. 350 Hills Street, Suite 106 Richland, WA 99354-5411 USA |
THE BUYER and THE SELLER have mutually agreed on the following: For payments under the present Contract valid banking details of the Seller are the following: Isotope - Regional Alliance, Joint-Stock Company (Isotope JSC), 119435, Moscow, 22 Pogodinskaya str. Acc. № [**] in Gazprombank (Open Joint-stock Company) SWIFT: GAZPRUMM |
All other terms and conditions are in accordance with Contract No. 840/08625142/31/22-21, Addendum 1-3. The present Addendum No.4 is an integral part of the Contract and may be signed via facsimile or e- mail. |
/s/ Konstantin Ershov, Head of Supplies, April 11, 2022 THE SELLER |
/s/ Jonathan Hunt, CFO, April 4, 2022 THE BUYER |